Thomas King, MD
Orthopaedic Surgery · Portsmouth, NHNPI 1376539387
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,500 of the $2,406 with a category attached, or 62.3%. Innovation Technologies Inc accounts for 67.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2023 at $1,736 and has fallen 98.7% since, to $23 in 2025. That places this record below the midpoint for orthopaedic surgery clinicians in NH, where the typical reported total is $2,654.
Across 12 payments — averaging $200.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Innovation Technologies Inc$2K
- Pacira Pharmaceuticals Incorporated$459
- Johnson & Johnson$212
- Smith+Nephew$88
- Vertex$23
- Medical Device Business Services, Inc.$14
What the payments were for
- Consulting fees$1,50062%
- Food & beverage$90638%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Innovation Technologies Inc | 2 | $1,611 |
| Pacira Pharmaceuticals Incorporated | 5 | $459 |
| Johnson & Johnson | 2 | $212 |
| Smith+Nephew | 1 | $88 |
| Vertex | 1 | $23 |
| Medical Device Business Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,406 in reported general payments places this provider in the 45th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 14 | $347 |
| Amoxicillin | 194 | $343 |
| Diclofenac Sodium | 29 | $306 |
| Clindamycin Hcl | 30 | $62 |
| Meloxicam | 20 | $48 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Portsmouth
- Akhilesh SastryPortsmouth$966K
- Mayo NoerdlingerPortsmouth$529K
- Michael MorwoodPortsmouth$506K
- Theodore GuildPortsmouth$4K
- Brian BarryPortsmouth$4K
- Ryan LabellePortsmouth$4K
- William SutherlandPortsmouth$4K
- John-Erik BellLebanon$528K
- Ira ParsonsSomersworth$245K
- Alexander OremLebanon$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.